Literature DB >> 33633729

Antibody Responses to Crude Gametocyte Extract Predict Plasmodium falciparum Gametocyte Carriage in Kenya.

Brian R Omondi1,2, Michelle K Muthui1, William I Muasya1, Benedict Orindi1, Ramadhan S Mwakubambanya2, Teun Bousema3, Chris Drakeley4, Kevin Marsh1,5, Philip Bejon1,5, Melissa C Kapulu1,5.   

Abstract

Background: Malaria caused by Plasmodium falciparum remains a serious global public health challenge especially in Africa. Interventions that aim to reduce malaria transmission by targeting the gametocyte reservoir are key to malaria elimination and/or eradication. However, factors that are associated with gametocyte carriage have not been fully explored. Consequently, identifying predictors of the infectious reservoir is fundamental in the elimination campaign.
Methods: We cultured P. falciparum NF54 gametocytes (to stage V) and prepared crude gametocyte extract. Samples from a total of 687 participants (aged 6 months to 67 years) representing two cross-sectional study cohorts in Kilifi, Kenya were used to assess IgG antibody responses by ELISA. We also analyzed IgG antibody responses to the blood-stage antigen AMA1 as a marker of asexual parasite exposure. Gametocytemia and asexual parasitemia data quantified by microscopy and molecular detection (QT-NASBA) were used to determine the relationship with antibody responses, season, age, and transmission setting. Multivariable logistic regression models were used to study the association between antibody responses and gametocyte carriage. The predictive power of the models was tested using the receiver operating characteristic (ROC) curve.
Results: Multivariable logistic regression analysis showed that IgG antibody response to crude gametocyte extract predicted both microscopic (OR=1.81 95% CI: 1.06-3.07, p=0.028) and molecular (OR=1.91, 95% CI: 1.11-3.29, p=0.019) P. falciparum gametocyte carriage. Antibody responses to AMA1 were also associated with both microscopic (OR=1.61 95% CI: 1.08-2.42, p=0.020) and molecular (OR=3.73 95% CI: 2.03-6.74, p<0.001) gametocytemia. ROC analysis showed that molecular (AUC=0.897, 95% CI: 0.868-0.926) and microscopic (AUC=0.812, 95% CI: 0.758-0.865) multivariable models adjusted for gametocyte extract showed very high predictive power. Molecular (AUC=0.917, 95% CI: 0.891-0.943) and microscopic (AUC=0.806, 95% CI: 0.755-0.858) multivariable models adjusted for AMA1 were equally highly predictive.
Conclusion: In our study, it appears that IgG responses to crude gametocyte extract are not an independent predictor of gametocyte carriage after adjusting for AMA1 responses but may predict gametocyte carriage as a proxy marker of exposure to parasites. Serological responses to AMA1 or to gametocyte extract may facilitate identification of individuals within populations who contribute to malaria transmission and support implementation of transmission-blocking interventions.
Copyright © 2021 Omondi, Muthui, Muasya, Orindi, Mwakubambanya, Bousema, Drakeley, Marsh, Bejon and Kapulu.

Entities:  

Keywords:  Plasmodium falciparum; antibody response; gametocyte extract; gametocytemia; malaria transmission

Year:  2021        PMID: 33633729      PMCID: PMC7902058          DOI: 10.3389/fimmu.2020.609474

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  42 in total

1.  Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers.

Authors:  C J Drakeley; J T Bousema; N I J Akim; K Teelen; W Roeffen; A H Lensen; M Bolmer; W Eling; R W Sauerwein
Journal:  Parasite Immunol       Date:  2006-05       Impact factor: 2.280

Review 2.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Molecular evidence for the localization of Plasmodium falciparum immature gametocytes in bone marrow.

Authors:  Ruth Aguilar; Ariel Magallon-Tejada; Ariel H Achtman; Cinta Moraleda; Regina Joice; Pau Cisteró; Connie S N Li Wai Suen; Augusto Nhabomba; Eusebio Macete; Ivo Mueller; Matthias Marti; Pedro L Alonso; Clara Menéndez; Louis Schofield; Alfredo Mayor
Journal:  Blood       Date:  2013-12-13       Impact factor: 22.113

4.  Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya.

Authors:  Tabitha W Mwangi; Amanda Ross; Robert W Snow; Kevin Marsh
Journal:  J Infect Dis       Date:  2005-04-26       Impact factor: 5.226

5.  Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission.

Authors:  André Lin Ouédraogo; Teun Bousema; Petra Schneider; Sake J de Vlas; Edith Ilboudo-Sanogo; Nadine Cuzin-Ouattara; Issa Nébié; Will Roeffen; Jan Peter Verhave; Adrian J F Luty; Robert Sauerwein
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

6.  Why so few transmission stages? Reproductive restraint by malaria parasites.

Authors:  L H Taylor; A F Read
Journal:  Parasitol Today       Date:  1997-04

7.  Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.

Authors:  Spencer D Polley; Tabitha Mwangi; Clemens H M Kocken; Alan W Thomas; Sheetij Dutta; David E Lanar; Ed Remarque; Amanda Ross; Thomas N Williams; Gabrielle Mwambingu; Brett Lowe; David J Conway; Kevin Marsh
Journal:  Vaccine       Date:  2004-12-16       Impact factor: 3.641

8.  Gametocyte carriage in an era of changing malaria epidemiology: A 19-year analysis of a malaria longitudinal cohort.

Authors:  Michelle K Muthui; Polycarp Mogeni; Kennedy Mwai; Christopher Nyundo; Alex Macharia; Thomas N Williams; George Nyangweso; Juliana Wambua; Daniel Mwanga; Kevin Marsh; Philip Bejon; Melissa C Kapulu
Journal:  Wellcome Open Res       Date:  2019-05-28

9.  Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity.

Authors:  Bronner P Gonçalves; Melissa C Kapulu; Patrick Sawa; Wamdaogo M Guelbéogo; Alfred B Tiono; Lynn Grignard; Will Stone; Joel Hellewell; Kjerstin Lanke; Guido J H Bastiaens; John Bradley; Issa Nébié; Joyce M Ngoi; Robin Oriango; Dora Mkabili; Maureen Nyaurah; Janet Midega; Dyann F Wirth; Kevin Marsh; Thomas S Churcher; Philip Bejon; Sodiomon B Sirima; Chris Drakeley; Teun Bousema
Journal:  Nat Commun       Date:  2017-10-26       Impact factor: 14.919

10.  A saliva-based rapid test to quantify the infectious subclinical malaria parasite reservoir.

Authors:  Dingyin Tao; Brent McGill; Timothy Hamerly; Tamaki Kobayashi; Prachi Khare; Amanda Dziedzic; Tomasz Leski; Andrew Holtz; Bruce Shull; Anne E Jedlicka; Andrew Walzer; Paul D Slowey; Christopher C Slowey; Sandrine E Nsango; David A Stenger; Mike Chaponda; Modest Mulenga; Kathryn H Jacobsen; David J Sullivan; Sadie J Ryan; Rashid Ansumana; William J Moss; Isabelle Morlais; Rhoel R Dinglasan
Journal:  Sci Transl Med       Date:  2019-01-02       Impact factor: 17.956

View more
  2 in total

1.  Characterization of Naturally Acquired Immunity to a Panel of Antigens Expressed in Mature P. falciparum Gametocytes.

Authors:  Michelle K Muthui; Eizo Takashima; Brian R Omondi; Christine Kinya; William I Muasya; Hikaru Nagaoka; Kennedy W Mwai; Benedict Orindi; Juliana Wambua; Teun Bousema; Chris Drakeley; Andrew M Blagborough; Kevin Marsh; Philip Bejon; Melissa C Kapulu
Journal:  Front Cell Infect Microbiol       Date:  2021-11-12       Impact factor: 5.293

2.  The acquisition of humoral immune responses targeting Plasmodium falciparum sexual stages in controlled human malaria infections.

Authors:  Roos M de Jong; Manon Alkema; Tate Oulton; Elin Dumont; Karina Teelen; Rie Nakajima; Rafael Ramiro de Assis; Kathleen W Dantzler Press; Priscilla Ngotho; Kevin K A Tetteh; Phil Felgner; Matthias Marti; Katharine A Collins; Chris Drakeley; Teun Bousema; Will J R Stone
Journal:  Front Immunol       Date:  2022-07-18       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.